FY2025 · period end Dec '25 · from the 10-K filed Feb 10, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $75.60B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001193125-26-275086 | Jun 15, 2026 | Jun 18, 2026 | Jun 18, 2026 13:12 UTC | EDGAR |
| 8-K | 0001193125-26-197278 | Apr 27, 2026 | Apr 30, 2026 | Apr 30, 2026 20:10 UTC | EDGAR |
| 10-Q | 0001193125-26-191444 | Mar 31, 2026 | Apr 29, 2026 | Apr 29, 2026 20:02 UTC | EDGAR |
| 8-K | 0001193125-26-187155 | Apr 23, 2026 | Apr 28, 2026 | Apr 28, 2026 20:20 UTC | EDGAR |
| 8-K | 0001193125-26-182265 | Apr 27, 2026 | Apr 27, 2026 | Apr 27, 2026 20:41 UTC | EDGAR |
| 8-K | 0001193125-26-174933 | Apr 24, 2026 | Apr 24, 2026 | Apr 24, 2026 11:11 UTC | EDGAR |
| 8-K | 0001193125-26-071880 | Feb 20, 2026 | Feb 25, 2026 | Feb 25, 2026 21:43 UTC | EDGAR |
| 10-K | 0001193125-26-044769 | Dec 31, 2025 | Feb 10, 2026 | Feb 10, 2026 21:27 UTC | EDGAR |
Direct links to SEC EDGAR. HCA has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Assets·As of Dec 31, 2013
Minor restatementwas$28.8B
Revised down in a 10-K.
Assets·As of Dec 31, 2014
Minor restatementwas$31.2B
Revised down in a 10-K.
Liabilities·As of Dec 31, 2014
Minor restatementwas$37.7B
Revised down in a 10-K.
Other Sundry Liabilities, Current·As of Dec 31, 2013
Major restatementwas$749M
Revised up in a 10-K.
Other Sundry Liabilities, Current·As of Dec 31, 2022
Notable restatementwas$1.2B
Revised down in a 10-K.
Other Sundry Liabilities, Current·As of Dec 31, 2017
Notable restatementwas$849M
Revised down in a 10-K.
HCA is not the only one.
See every restatement we've found across the market — or get an alert the next time HCA revises a number.
Restatements are detected by comparing every vintage of a fact across all of HCA Healthcare, Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows HCA's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling HCA Healthcare, Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on HCA yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on HCA and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $64.97B |
| $60.23B |
| $58.75B |
| Gross Profit | — | — | — | — | — |
|---|
| Operating Income | — | — | — | — | — |
|---|
| Net Income | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B |
|---|
| EPS (Diluted) | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $60.72B | $59.51B | $56.21B | $52.44B | $50.74B |
| Total Liabilities | — | — | — | — | — |
| Stockholders' Equity | negative: -$2.77B | $0.56B | $1.06B | negative: -$0.07B | $1.49B |
| Cash & Equivalents | $1.04B | $1.93B | $0.94B | $0.91B | $1.45B |
| Total Debt | $46.93B | $43.40B | $39.93B | $38.38B | $34.83B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $12.64B | $10.51B | $9.43B | $8.52B | $8.96B |
| Capital Expenditures | $4.94B | $4.88B | $4.74B | $4.39B | $3.58B |
| Free Cash Flow | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Net Margin | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Return on Equity | negative: -244.8% | 713.3% | 494.5% | negative: -7730.1% | 317.6% |
| Return on Assets | 11.3% | 10.0% | 9.6% | 10.9% | 14.2% |
| Debt / Equity | negative: -16.94× | 78.20× | 37.67× | negative: -525.82× | 23.39× |
